Orion Exits Neuro To Concentrate On Cancer And Pain

Finnish Firm Refocuses R&D Strategy

 
• By Kevin Grogan
  
Digital illustration of Cancer cell in colour background
Cancer key focus for Orion • Source: Archive
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip